TrialThe lancet. Diabetes & endocrinology2017

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial.

Olga Vaccaro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.